Insulin resistance and beta cell function in chronically transfused patients of thalassemia major

Indian Pediatrics

Volumn 43, Issue 5, 2006, Pages 393-400

  Suvarna, Jyoti ^a,b   Ingle, Hemraj ^a   Deshmukh, C T ^a  

^a KEM HOSPITAL   (India)

^b Vakola Pipe line ^*  (India)

Author keywords

Beta cell function; Glucose intolerance; Insulin resistance

Indexed keywords

LIVER ENZYME;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CELL FUNCTION; CHELATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; IRON OVERLOAD; LIVER SIZE; MALE; SCHOOL CHILD; SPLENOMEGALY; THALASSEMIA;

ADOLESCENT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE;

EID: 33744468286     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Torres FA, Bonduel M, Sciuccati G, del Pozo A, Roldan A, Ciaccio M, et al. Beta thalassemia major in Argentina. Medicina 2002; 62: 124-134.
2. El-Hazmi M A, Al-Swailem A, Al-Fawaz I, Warsey A S, Al-Swailem A. Diabetes mellitus in children suffering from beta-thalassaemia. J Trop Pediatr 1994; 40: 26.
3. Khalifa A S, Salem M, Mounir E, El- Tawail M M, El Savvy, Manal M, et al. Abnormal glucose tolerance in Egyptian Beta thalassemic patients: Possible association in genotyping. Pediatr Diabetes 2004; 5: 126-132.
4. Flynn DM, Fairney A, Jackson D, Clayton BE. Hormonal changes in thalassaemia major. Arch Dis Child 1976; 51: 828- 836.
5. Cario H, Holl RW, Debatin KM, Kohne E. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary hemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr 2003; 162: 139-146.
6. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995; 42: 581-586.
7. Chern J P S, Lin Kai-Hsin, Lu Meng-Yao, Lin Dong-Tsam, Lin Kuo-Sin, Chen Jong-Dar, et al. Abnormal Glucose Tolerance in Transfusion-Dependent β-Thalassemic Patients. Diabetes Care 2001; 24: 850-854.
8. Arrigo T, Crisafulli G, Meo A, Sturiale M, Lombardo F, Miceli M, et al. Glucose tolerance, insulin secretion and peripheral sensitivity in thalassaemia major. J Pediatr Endocrinol Metab. 1998;11 Suppl 3: 863-866.
9. Rodriguez GC, Ortega AJJ, Alonso JL, Albisu M, Casaldaliga J, Diaz de Heredia C, et al. Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major. Med Clin 1994; 102: 721-724.
10. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988; 318: 809-814.
11. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab 1993; 77: 478-483.
12. Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients. J Pediatr Endocrinol Metab 1998; 11 Suppl 3: 867-869.
13. American Diabetes Association. Report on the Expert Committee on the diagnosis and the classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
14. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications Part 1: diagnosis and classification of diabetes mellitus. Provisional Report of a WHO consultation: Diabet Med 1998; 15: 539-553.
15. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucoseand insulin concentration in man. Diabetologica 1985; 28: 412-419.
16. Haffner S M, Gonzalez C, et al. Prospective Analysis of HOMA model. Diabetes Care 1996; 19: 1138-1141.
17. Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994; 331: 567-573.
18. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988; 318: 809-814.
19. Mangiagli A, Italia S, Campisi S. Glucose tolerance and Beta cell secretion in patients with thalassemia major. J Pediatr Endocrinol Metab 1998; 11: 985-986.
20. Grundy R G, Woods K A, Savage M O, Evans J P. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child 1994; 71: 128-132.
21. Monge L, Pinach S, Caramellino L, Bertero M T, Dall'omo A, Carta Q. The possible role of autoimmunity in the pathogenesis of diabetes in B-thalassemia major. Diabetes Metab 2001; 27: 149-154.
22. De Sanctis V, D'Ascola G, Wonke B. The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients. Postgrad Med J 1986; 62: 831-836.
23. Labropoulou-KC, Goritsas C, Fragopanagou H, Repandi M, Matsouka P, Alexandrides T. High prevalence of diabetes mellitus among adult beta-thalassaemic patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 1999; 11: 1033-1036.
24. Saudek CD, Hemm RM, Peterson CM. Abnormal glucose tolerance in beta thalssemia major. Metabolism 1977; 26: 43-52.
25. Sougleri M, Labropoulou-KC, Paraskevopoulou P, Fragopanagou H, Alexandrides T. Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major. Eur J Gastroenterol Hepatol 2001; 13: 1195-1199.
26. De Sanctis V, Zurlo MG, Senesi E, Boffa C, Cavallo L, Di Gregorio F. Insulin dependant diabetes in thalassemia. Arch Dis Child 1988; 63: 58-62.